University College London

Breakthrough treatments for leukaemia and aggressive cancers

UCL’s ground-breaking research has revolutionised the treatment of leukaemia and transformed the lives of patients with aggressive cancers.

By developing CAR T-cell therapy, which modifies the immune system to destroy cancer cells, UCL and partner hospitals have successfully treated childhood leukaemia.

UCL has also led major clinical trials and breakthroughs in diagnosing and treating other forms of cancer. These include doubling the accuracy of prostate cancer diagnoses, allowing over one million men a year to avoid an unnecessary biopsy.

Another breakthrough is the development of a single-shot dose of radiotherapy for use during breast cancer surgery to remove the need for weeks of postoperative radiotherapy.

Researcher profiles: